Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Revenue | 42M | 21M |
| Cost of revenue | 23M | 12M |
| Gross profit | 20M | 8M |
| Research and development | 4M | 2M |
| Selling, general and administrative | 15M | 10M |
| Operating expenses | 28M | 27M |
| Operating income | −8M | −19M |
| Interest expense | 271,633 | 317,234 |
| Pre-tax income | −8M | −19M |
| Income tax | 4M | — |
| Net income | −12M | −19M |
| Earnings per share | −0.06 | −0.11 |
| Earnings per share, diluted | −0.06 | −0.11 |
| Weighted average shares | 190M | 171M |
| Weighted average shares, diluted | 199M | 181M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 16M | 3M | 6M | 11M | 16M | 466,500 | 6M | 7M |
| Receivables | 14M | 12M | 7M |
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Operating cash flow | −19M | −10M |
| Depreciation and amortisation | 1M | 436,005 |
| Share-based compensation | 8M | 14M |
| Capital expenditure | 4M | 661,479 |
| Investing cash flow | −4M | −661,479 |
| Financing cash flow | 26M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 6M |
| 4M |
| 4M |
| 4M |
| 4M |
| Inventory | 17M | 17M | 20M | 18M | 14M | 10M | 9M | 7M |
| Current assets | 66M | 49M | 48M | 51M | 48M | 27M | 25M | 23M |
| Property, plant and equipment | 9M | 9M | 8M | 8M | 7M | 5M | 4M | 3M |
| Total assets | 91M | 74M | 70M | 70M | 63M | 42M | 39M | 36M |
| Current liabilities | 26M | 26M | 21M | 20M | 15M | 21M | 18M | 15M |
| Total liabilities | 36M | 36M | 30M | 28M | 23M | 29M | 25M | 21M |
| Equity | 55M | 38M | 40M | 42M | 41M | 13M | 14M | 15M |
| Shares outstanding | 200M | 194M | 194M | 194M | 194M | 172M | 171M | 171M |
| Shares issued | 200M | 194M | 194M | 194M | 194M | 172M | 171M | 171M |
| 9M |